Kieger is an independent asset manager that designs solutions for clients who care about making a positive difference, towards a more sustainable world.
To care is deeply engrained in our origins. For us, caring is an all-encompassing spirit, capturing the thought and attention that we give to both our clients, and to the world at large. It is an expression of our continuous strive to make a positive difference through everything we do. In our mind, care is also about the rigour, thoroughness and sharpness we apply to our work, resulting in holistic solutions for our clients that truly move everyone involved forward.
We call it “dare to care”.
At Kieger, we are generous in thought and action. We see generosity as a noble cause, and one central to who we are and how we behave. In our view, being generous means giving our clients the attention and dedication they need to navigate the complexity of investment. Being generous is also about caring for our world and for our society – about building a better future for the next generations. Our generosity towards our employees creates an environment in which people feel safe, enabling collaborative work so as to achieve the best solutions for our clients.
We go beyond helping our clients generate positive differences in monetary terms. At Kieger, we take our responsibility very seriously. Together with our clients, we strive to make a positive difference on society at large. We make a positive difference on our clients’ future, enabling them to live in a better world and, in turn, to do good with their wealth that we help grow safely. Making a positive difference is first and foremost a mindset for everyone at Kieger: how to impact the future of our world and how we, as investment manager, can play a role in making it a better place.
We place the utmost importance on servicing our clients efficiently and swiftly, sharing our unique expertise with them. We strive to be more than smart professionals. We aim to be truly thorough in everything we do and the sharpness, depth and rigour that we apply to our work can hopefully be felt by everyone we engage with – both internally and externally. Each of our areas of expertise is managed by specialists with long- standing experience and deep knowledge. The collaboration between our teams leverages this knowledge and provides our clients with holistic investment solutions.
Healthcare is a dynamic sector with strong, unique long-term drivers and proven resilience to economic volatility. Thanks to in-depth knowledge and experience across all the different subsectors, Kieger has established itself as a holistic specialist Healthcare asset manager.
Sustainability is of paramount importance to Kieger. We integrate ESG criteria into our financial analysis so as to minimise downside risks, maximise upside potential and, more generally, address social and environmental changes that are reshaping the planet. It is our way of contributing to a brighter future for all.
Kieger is a long-standing investor in «Mittelstand» companies, as well as leading Private Equity funds worldwide. We also manage one of the first Private Equity fund of funds dedicated to Healthcare.
Kieger designs and manages diversified Multi Asset portfolios utilising a broad range of asset classes and thematic investment products. Our seasoned team has a long track record in selecting managers to implement innovative strategies with our global partners.
The huge withdrawal of central bank liquidity happening currently is truly “unprecedented” (an otherwise-overused term currently). Despite all of the detailed analysis on the effects of quantitative tightening no one can predict the full impact this will have, but it is certainly not Fed Chair Yellen’s 2017 expectation of “watching paint dry”.
Did you know that R&D expenses of the 15 biggest pharma companies have increased by almost 50% since 2016 to USD 133 bn in 2021? And expenses will continue to increase. Roche alone for example will spend close to CHF 15 bn on R&D in 2022, 1 bn more than in 2021.
We attended the ESMO (European Society for Medical Oncology) annual oncology congress in Paris from Sept. 9-13. We came away very positive from the meeting, though two souls remain in our chest. On one side we see the amazing potential and the opportunities for new oncology therapies. On the other side complexity seems to potentially increase and so does competition in the space. But what to do as an investor? Find some proposals in our ESMO Thoughts from the Street.